Related Article: Nearly twice as many patients in deprived areas prescribed dependency-forming meds
US pharmacy chain Walgreens has completed its takeover of UK high multiple high-street pharmacist Alliance Boots.
Officially announced on 31 December 2014, the merger was finalised after Walgreen opted to purchase a 55% stake in the company, taking full control over the UK multiple.
The US pharmacy purchased a 45% stake in Boots Alliance in 2012.
Related Article: Finding sustainable funding solution is ‘matter of urgency’ for government
Now renamed Walgreens Boots Alliance (WBA), the company consists of Walgreens, Boots and Alliance Healthcare, a pharmaceutical wholesaler and distributor.
Walgreen Boots Alliance has a pharmaceutical network across the US, Europe and key markets in Asia and Latin America.
Acting CEO of WBA, Stefano Pessina, said: “Becoming global gives us the ability to generate significant and sustainable benefits for local markets and all stakeholders, from consumers and patients, to pharmacists, suppliers, business partners and our employees.”
Related Article: NICE recommends ‘game changer’ wearable tech for type 1 diabetes
Combined, WBA now has more than 12,000 stores in 25 countries, employing almost 400,000 people.
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.